WallStSmart

Bio Green Med Solution, Inc. (BGMS)vsLennox International Inc (LII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lennox International Inc generates 284811% more annual revenue ($5.30B vs $1.86M). LII leads profitability with a 14.9% profit margin vs -118.3%. LII earns a higher WallStSmart Score of 62/100 (C+).

BGMS

Hold

46

out of 100

Grade: D+

Growth: 6.3Profit: 2.0Value: 5.0Quality: 5.8
Piotroski: 4/9Altman Z: -77.25

LII

Buy

62

out of 100

Grade: C+

Growth: 4.0Profit: 8.5Value: 7.0Quality: 6.0
Piotroski: 3/9Altman Z: 4.22

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BGMS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
710.0%10/10

Revenue surging 710.0% year-over-year

LII5 strengths · Avg: 8.8/10
Return on EquityProfitability
59.7%10/10

Every $100 of equity generates 60 in profit

Altman Z-ScoreHealth
4.2210/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.998/10

Growing faster than its price suggests

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Areas to Watch

BGMS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$5.78M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-46.1%2/10

ROE of -46.1% — below average capital efficiency

Free Cash FlowQuality
$-352,0002/10

Negative free cash flow — burning cash

LII4 concerns · Avg: 3.8/10
Price/BookValuation
9.6x4/10

Trading at 9.6x book value

Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

EPS GrowthGrowth
0.1%4/10

0.1% earnings growth

Debt/EquityHealth
1.563/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : BGMS

The strongest argument for BGMS centers on Price/Book, Revenue Growth. Revenue growth of 710.0% demonstrates continued momentum.

Bull Case : LII

The strongest argument for LII centers on Return on Equity, Altman Z-Score, PEG Ratio. PEG of 0.99 suggests the stock is reasonably priced for its growth.

Bear Case : BGMS

The primary concerns for BGMS are EPS Growth, Market Cap, Return on Equity.

Bear Case : LII

The primary concerns for LII are Price/Book, Revenue Growth, EPS Growth. Debt-to-equity of 1.56 is elevated, increasing financial risk.

Key Dynamics to Monitor

BGMS profiles as a hypergrowth stock while LII is a value play — different risk/reward profiles.

LII carries more volatility with a beta of 1.18 — expect wider price swings.

BGMS is growing revenue faster at 710.0% — sustainability is the question.

LII generates stronger free cash flow (136M), providing more financial flexibility.

Bottom Line

LII scores higher overall (62/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bio Green Med Solution, Inc.

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. The company is headquartered in Kuala Lumpur, Malaysia.

Lennox International Inc

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Lennox International Inc. designs, manufactures and markets a range of products for the heating, ventilation, air conditioning and refrigeration markets in the United States, Canada and internationally. The company is headquartered in Richardson, Texas.

Want to dig deeper into these stocks?